Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1368 ARTÍCULOS , VIENDO DEL 481 AL 495

Combination therapy for Alzheimer's disease and related dementias

Bednar MM.

Prog Mol Biol Transl Sci. 2019;168:289-296. doi: 10.1016/bs.pmbts.2019.10.001. Epub 2019 Oct 24.

Using mirror-image peptides to enhance robustness and reproducibility in studying the amyloid β-protein

Kuhn AJ, Raskatov JA.

Prog Mol Biol Transl Sci. 2019;168:57-67. doi: 10.1016/bs.pmbts.2019.05.010. Epub 2019 Jun 18.

In search of pathogenic amyloid β-peptide in familial Alzheimer's disease

Wolfe MS.

Prog Mol Biol Transl Sci. 2019;168:71-78. doi: 10.1016/bs.pmbts.2019.07.002. Epub 2019 Jul 13.

Biology of splicing in Alzheimer's disease research

Nagata K, Saito T, Saido TC, Morihara T.

Prog Mol Biol Transl Sci. 2019;168:79-84. doi: 10.1016/bs.pmbts.2019.08.003. Epub 2019 Oct 17.

Acquired cerebral amyloid angiopathy: An emerging concept

Yamada M, Hamaguchi T, Sakai K.

Prog Mol Biol Transl Sci. 2019;168:85-95. doi: 10.1016/bs.pmbts.2019.05.012. Epub 2019 Jun 18.

Blood-brain barrier and innate immunity in the pathogenesis of Alzheimer's disease

Šimić G, Španić E, Langer Horvat L, Hof PR.

Prog Mol Biol Transl Sci. 2019;168:99-145. doi: 10.1016/bs.pmbts.2019.06.003. Epub 2019 Jul 3.

Inflammasome-mediated innate immunity in Alzheimer's disease

Venegas C, Heneka MT.

FASEB J. 2019 Dec;33(12):13075-13084. doi: 10.1096/fj.201900439. Epub 2019 Nov 8.

Carotenoids as Novel Therapeutic Molecules Against Neurodegenerative Disorders: Chemistry and Molecular Docking Analysis

Lakey-Beitia J, Kumar D J, Hegde ML, Rao KS.

Int J Mol Sci. 2019 Nov 7;20(22):5553. doi: 10.3390/ijms20225553.

ApoE4-Induced Cholesterol Dysregulation and Its Brain Cell Type-Specific Implications in the Pathogenesis of Alzheimer's Disease

Jeong W, Lee H, Cho S, Seo J.

Mol Cells. 2019 Nov 30;42(11):739-746. doi: 10.14348/molcells.2019.0200.

The role of cell type-specific mitochondrial dysfunction in the pathogenesis of Alzheimer's disease

Kim DK, Mook-Jung I.

BMB Rep. 2019 Dec;52(12):679-688. doi: 10.5483/BMBRep.2019.52.12.282.

Editorial: Multi Target - Directed Ligands in the Treatment of Alzheimer's Disease

Soukup O, Korabecny J.

Curr Alzheimer Res. 2019;16(9):771. doi: 10.2174/156720501609191029115310.

Validation Prognostic of the Baylor Profound Mental Status Examination

Salmerón S, Lozoya S, Plaza L, Soler-Moratalla I, Solís J, Abizanda P.

Dement Geriatr Cogn Disord. 2019;48(1-2):113-122. doi: 10.1159/000504168. Epub 2019 Nov 18.

Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer's Disease

Cioffi F, Adam RHI, Broersen K.

J Alzheimers Dis. 2019;72(4):981-1017. doi: 10.3233/JAD-190863.

Validation of a priori candidate Alzheimer's disease SNPs with brain amyloid-beta deposition

Vacher M, Porter T, Villemagne VL, Milicic L, Peretti M, Fowler C, Martins R, Rainey-Smith S, Ames D, Masters CL, Rowe CC, Doecke JD, Laws SM.

Sci Rep. 2019 Nov 19;9(1):17069. doi: 10.1038/s41598-019-53604-5.

Metal ions and degenerative diseases

Quintanar L, Lim MH.

J Biol Inorg Chem. 2019 Dec;24(8):1137-1139. doi: 10.1007/s00775-019-01744-4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias